Persistent Response to a Combination Treatment Featuring a Targeted Agent and an Immune Checkpoint Inhibitor in a Patient With Collecting Duct Renal Carcinoma: A Case Report and Literature Review.

Zhou, Weimin; Huang, Ji; He, Qiuming; Luo, Qingfeng; Zhang, Xiaofang; Tao, Xuewei; Dong, Hanzhi; Tu, Xinhua

Zhou, Weimin; Huang, Ji; He, Qiuming; Luo, Qingfeng; Zhang, Xiaofang; Tao, Xuewei; Dong, Hanzhi; Tu, Xinhua.

Afiliación

Zhou W; Department of Urology, Jiangxi Cancer Hospital of Nanchang University, Jiangxi Cancer Center, Nanchang, China.
Huang J; Department of Urology, Jiangxi Cancer Hospital of Nanchang University, Jiangxi Cancer Center, Nanchang, China.
He Q; Department of Urology, Jiangxi Cancer Hospital of Nanchang University, Jiangxi Cancer Center, Nanchang, China.
Luo Q; Department of Pathology, Jiangxi Cancer Hospital of Nanchang University, Jiangxi Cancer Center, Nanchang, China.
Zhang X; Department of Pathology, Jiangxi Cancer Hospital of Nanchang University, Jiangxi Cancer Center, Nanchang, China.
Tao X; Department of Radiology, Jiangxi Cancer Hospital of Nanchang University, Jiangxi Cancer Center, Nanchang, China.
Dong H; Department of Internal Medical Oncology, Jiangxi Cancer Hospital of Nanchang University, Jiangxi Cancer Center, Nanchang, China.
Tu X; Department of Urology, Jiangxi Cancer Hospital of Nanchang University, Jiangxi Cancer Center, Nanchang, China.

Front Oncol ; 11: 764352, 2021.

Article en En | MEDLINE | ID: mdl-34820330

Palabras clave

collecting duct carcinoma; immune checkpoint inhibitor; immunotherapy; kidney cancer; targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google